Filing Details

Accession Number:
0001179110-16-016896
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-01-04 16:09:13
Reporting Period:
2016-01-04
Filing Date:
2016-01-04
Accepted Time:
2016-01-04 16:09:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
855654 Immunogen Inc IMGN Pharmaceutical Preparations (2834) 042726691
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1198338 John Lambert C/O Immunogen, Inc.
830 Winter Street
Waltham MA 02451
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-01-04 3,889 $3.19 110,746 No 4 M Direct
Common Stock Disposition 2016-01-04 3,889 $13.20 106,857 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2016-01-04 3,889 $3.19 3,889 $3.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,778 2007-06-08 2016-06-08 No 4 M Direct
Footnotes
  1. Weighted average price of shares sold.
  2. The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan executed by the reporting person on February 20, 2015.
  3. Exercisable as to 11,667 shares commencing on June 8, 2007, 11,667 shares commencing on June 8, 2008, and 11,666 shares commencing on June 8, 2009.